203 related articles for article (PubMed ID: 10622049)
1. Low-dose dopamine infusion in cirrhosis with refractory ascites.
Lin SM; Lee CS; Kao PF
Int J Clin Pract; 1998; 52(8):533-6. PubMed ID: 10622049
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
3. Low-dose dopamine infusion, renal haemodynamics and urinary albumin excretion rate in insulin-dependent diabetics and in normal man.
Christiansen JS; Pedersen MM; Schmitz A; Christensen CK; Christensen T; Mogensen CE
Scand J Clin Lab Invest; 1988 Nov; 48(7):679-83. PubMed ID: 3201101
[TBL] [Abstract][Full Text] [Related]
4. Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery.
Sumeray M; Robertson C; Lapsley M; Bomanji J; Norman AG; Woolfson RG
J Nephrol; 2001; 14(5):397-402. PubMed ID: 11730274
[TBL] [Abstract][Full Text] [Related]
5. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
6. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
Salerno F; Incerti P; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Ghirardi P
Arch Intern Med; 1990 Jan; 150(1):65-9. PubMed ID: 1967522
[TBL] [Abstract][Full Text] [Related]
7. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
[TBL] [Abstract][Full Text] [Related]
8. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
[TBL] [Abstract][Full Text] [Related]
9. Renal function following sea snake venom (Lapemis hardwicki) administration in dogs treated with sodium bicarbonate solution.
Sakwiwatkul K; Chaiyabutr N; Sitprija V
J Nat Toxins; 2002 May; 11(2):111-21. PubMed ID: 12009111
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-dose dopamine on renal function in uninephrectomized patients: special emphasis on kidney donors before and after nephrectomy.
ter Wee PM; Tegzess AM; Donker AJ
Clin Nephrol; 1987 Nov; 28(5):211-6. PubMed ID: 3427830
[TBL] [Abstract][Full Text] [Related]
11. Measurement of renal functional reserve of the single kidney in man.
Wheeler DC; Cosgriff PS; Bennett SE; Walls J
Clin Nephrol; 1987 Aug; 28(2):87-92. PubMed ID: 3652543
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose dopamine on kidney function and vasoactive hormones in pediatric patients with advanced renal failure.
Tulassay T; Rascher W; Schärer K
Clin Nephrol; 1987 Jul; 28(1):22-7. PubMed ID: 3621687
[TBL] [Abstract][Full Text] [Related]
13. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
[TBL] [Abstract][Full Text] [Related]
14. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
[TBL] [Abstract][Full Text] [Related]
16. The effect of dopamine on renal function in solitary partial nephrectomy surgery.
O'Hara JF; Hsu TH; Sprung J; Cywinski JB; Rolin HA; Novick AC
J Urol; 2002 Jan; 167(1):24-8. PubMed ID: 11743267
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study.
Funasaki T; Tsutsumi M; Takase S; Tsuchishima M; Ueshima Y; Urashima S; Shimanaka K; Itoh T; Kawahara H
Am J Gastroenterol; 1999 Sep; 94(9):2475-81. PubMed ID: 10484011
[TBL] [Abstract][Full Text] [Related]
18. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
[TBL] [Abstract][Full Text] [Related]
19. Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
Woitas RP; Flommersfeld S; Stoffel-Wagner B; Schiedermaier P; Brensing KA; Spengler U; Sauerbruch T
Scand J Gastroenterol; 2002 Nov; 37(11):1321-7. PubMed ID: 12465732
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic cirrhosis with refractory ascitis and changes in renal function: effects of the infusion of fresh plasma and furosemide].
Bardi A; Orozco R; Sapunar J; Fernández I
Rev Med Chil; 1989 Jul; 117(7):740-6. PubMed ID: 2519427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
